Stock screenerAll disclosures →
EDGAR →
IDXX
Conviction 47HealthcareScan · Mon, Aug 10, 2026IDXX$595.83+1.56%
ResistanceSupportVol 14Congress buyCongress sellVol MA14 733.39K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price595.83
Change+1.56%
Gap+0.65%
Rel volume2.11×
Avg volume699.45K
Avg $ vol398.58M
SMA 20565.64
SMA 50560.52
SMA 200618.92
Price vs 50+6.30%
Price vs 200-3.73%
MA stackmixed
50/200 cross—
Supertrendup · 540.44
RSI (14)63
MACD hist3.86
MACD crossbull · 9d
Stoch %K / %D68 / 63
ADX (14)16
+DI / −DI31 / 17
RSI divergence—
MACD divergence—
ATR %+3.40%
ADR %3.25%
52w high766.68
52w low526.44
From 52w high-22.28%
Above 52w low+13.18%
New 52w highNo
SqueezeOff
Bollinger width11.82%
%B0.95
Donchian pos68.46%
Donchian high624.15
Donchian low534.36
AVWAP (52w high)603.41
vs AVWAP high-1.26%
AVWAP (52w low)565.69
vs AVWAP low+5.33%
OBV trendUp
Chaikin MF (20)-0.13
Today vs 20d2.11×
Avg vol (14d)733.39K
Avg vol (20d)699.45K
Avg $ vol (20d)398.58M
Market cap46.94B
RS 3m (vs SPY)-3.17%
RS 6m (vs SPY)-22.96%
RS line new highNo
Trend template2/8
Technical rank46.6
1 week+4.93%
1 month+5.72%
3 months+6.38%
6 months-7.57%
1 year-8.34%
YTD-11.07%
P/E44.31
P/B29.11
P/S10.91
P/FCF44.40
EPS13.08
Div yield—
ROE65.70%
ROA30.78%
Debt/Eq0.28
Current1.17
EV/EBITDA31.35
Gross margin61.80%
Net margin24.62%
Rev growth10.42%
EPS growth19.33%
Price target696.00
Target upside16.81%
Analyst ratingBuy
Institutional107.49%
Ent. value47.19B
Revenue1.22B
Net income338.41M
Gross profit779.09M
Free cash flow1.06B
IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
ExchangeNasdaq
Shares out78.88M
Employees11K
ListedFri, Jun 21, 1991
Free float78.58M
Float %99.6%
Short interest2.1M
Days to cover3.0d
Short volume56.1%
Squeeze score46 / 100
Next earnings—
EPS forecast—
Last EPS vs est$4.27 vs $3.95
Last surprise+8.1% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank46.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance602.76
Support526.46
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Signal lifecycle
How this symbol has moved through the lanes across 47 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Breaking out nowJun 91 scan
- Setting upJun 15 – Aug 36 scans
- Breaking out nowAug 41 scan
Congress activity
Disclosed STOCK Act trades in IDXX · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
April McClain Delaney house · D · MD · traded 2026-01-13 | Sell | $1K–$15K | 2026-01-13 | 2026-02-02 | |
Byron Donalds house · R · FL · traded 2025-09-04 | Buy | $1K–$15K | 2025-09-04 | 2025-10-07 | |
April McClain Delaney house · D · MD · traded 2025-08-07 | Sell | $1K–$15K | 2025-08-07 | 2025-09-02 | |
April McClain Delaney house · D · MD · traded 2025-07-09 | Sell | $1K–$15K | 2025-07-09 | 2025-08-05 | |
Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $100K–$250K | 2025-05-12 | 2025-06-22 | |
Rob Bresnahan house · PA · traded 2025-05-15 | Buy | $1K–$15K | 2025-05-15 | 2025-06-09 | |
Jefferson Shreve house · R · IN · traded 2025-04-07 | Buy | $50K–$100K | 2025-04-07 | 2025-05-08 | |
April McClain Delaney house · D · MD · traded 2025-04-09 | Buy | $1K–$15K | 2025-04-09 | 2025-05-02 | |
April McClain Delaney house · D · MD · traded 2025-04-04 | Buy | $1K–$15K | 2025-04-04 | 2025-05-02 | |
April McClain Delaney house · D · MD · traded 2025-04-07 | Buy | $1K–$15K | 2025-04-07 | 2025-05-02 |
Insider activity
SEC Form 4 transactions in IDXX · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
FENNELL GEORGE Executive Vice President · Restricted Stock Unit · 2026-06-01 | Exercise | 639 | — | 2026-06-01 | 2026-06-02 |
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01 | Tax | 284 | $161K | 2026-06-01 | 2026-06-02 |
FENNELL GEORGE Executive Vice President · Common Stock · 2026-06-01 | Exercise | 639 | $0 | 2026-06-01 | 2026-06-02 |
Kingsley Lawrence D Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12 | Grant | 525 | $0 | 2026-05-12 | 2026-05-14 |
ESSIG STUART Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12 | Grant | 525 | $0 | 2026-05-12 | 2026-05-14 |
SAMAD SAM Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12 | Grant | 525 | $0 | 2026-05-12 | 2026-05-14 |
ESSIG STUART Director · Restricted Stock Unit · 2026-05-12 | Grant | 234 | $0 | 2026-05-12 | 2026-05-14 |
HOOLEY JOSEPH L Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12 | Grant | 525 | $0 | 2026-05-12 | 2026-05-14 |
Britt Irene Chang Director · Non-Qualified Stock Option (right-to-buy) · 2026-05-12 | Grant | 525 | $0 | 2026-05-12 | 2026-05-14 |
JUNIUS DANIEL M Director · Restricted Stock Unit · 2026-05-12 | Grant | 234 | $0 | 2026-05-12 | 2026-05-14 |
SEC filings
EDGAR filings in IDXX · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.